Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation. (Q47865904)

From Wikidata

Jump to navigation Jump to search

scientific article published on 5 August 2013

Language	Label	Description	Also known as
English	Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.	scientific article published on 5 August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

based on heuristic

inferred from title

aplastic anemia

1 reference

based on heuristic

inferred from title

Antonio Pagliuca

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

J C Marsh

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

R M Pearce

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M B C Koh

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Z Lim

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

G J Mufti

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J Perry

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J A Snowden

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A J Vora

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

N Russell

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

B Gibson

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

D Milligan

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

P Veys

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

S Samarasinghe

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M McMullin

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

K Kirkland

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

G Cook

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

British Society for Blood and Marrow Transplantation, Clinical Trials Committee

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

0 references

publication date

5 August 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

49

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

42-48

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23912664%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

https://scigraph.springernature.com/pub.10.1038/bmt.2013.115

0 references

Allogeneic stem cell transplantation for aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Treatment and hematopoietic SCT in aplastic anemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Guidelines for the diagnosis and management of aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Nonmalignant late effects after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.115

21 January 2018

Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome after marrow transplantation for severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT rando

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23912664

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47865904&oldid=1528478210"